Abstract
An efficient enantioselective synthesis of cermizine D has been developed that exploits the use of a common intermediate to access over 85% of the carbon backbone. Key steps include an organocatalyzed heteroatom Michael addition, a diastereoselective alkylation with α-iodomethyl phenyl sulfide, a conjugate addition to a vinyl sulfone species and a sulfone coupling / desulfurization sequence to join the two major subunits.
Cermizine D (1) was isolated in 2004 by Kobayashi and co-workers from the club moss Lycopodium cernuum and displaced modest cytotoxicity aginst murin lymphoma L1210 cells (7.5 μg / mL).1 Related cermizine alkaloids have attracted the attention of several laboratories.2 To date, one elegant eighteen-step total synthesis of 1 has been reported by Takayama and co-workers.3 Herein, we report an efficient, enantioselective synthesis of cermizine D, which exploits the use of a common intermediate strategy to access two of the three piperidine rings.
Our retrosynthetic strategy is shown in Scheme 1. We envision that the C7-N bond could be formed through an intramolecular SN2-type cyclization of alcohol 2. Alcohol 2 would in turn be accessible from a sulfone-aldehyde coupling / desulfurization sequence using sulfone 3 and common intermediate 4. Sulfone 3 would be accessible from the same common intermediate 4.
Scheme 1.
Retrosynthetic Analysis.
The synthesis commenced with the commercially available amine 5 (Scheme 2). The amine can also be conveniently prepared from 1-bromo-5-hexene through a two-step sequence.4 Subsequent Boc protection gave the known alkene 6.5 After cross-metathesis using crotonaldehyde, intramolecular heteroatom Michael addition (under a slight modification of our previously reported conditions4) employing catalyst 96 cleanly generated the piperidine 4 in 85% yield and 96% ee as determined by chiral HPLC analysis.5,7
Scheme 2.
Synthesis of Common Intermediate.
Our first generation approach for the conversion of the common intermediate 4 into sulfone 3 is shown in Scheme 3. Homogolation via Wittig olefination and enol ether cleavage revealed aldehyde 11. Pinnick oxidation followed by coupling with Evans oxazolidinone 12 generated compound 13. Diastereoselective alkylation8 was best achieved using NaHMDS as base to provide a good yield of methyl product 15 in modest diastereoselectivity (1.5:1 dr). The absolute stereochemistry of alkylation product 15 was determined by x-ray crystallographic analysis (Figure 1). The poor level of diastereoselectivity appears to be a result of a mis-matched stereochemical array in 13; use of the diastereomeric oxazolidinone series 14 generated the alkylated product 17 in high levels of stereoselectivity (20:1 dr). Subsequent reductive removal of the oxazolidinone 15 followed by conversion to the sulfide and oxidation generated the sulfone 3.
Scheme 3.
Synthesis of Sulfone Fragment.
Figure 1.
ORTEP Representation of the X-Ray Crystallographic Data of Compound 15.
Given poor diastereoselectivity in constructing the C15 stereoogenic center, we sought an alternate approach (Scheme 4). We were intrigued by the possibility of exploiting the matched stereochemistry showcased in the alkylation with oxazolidinone 14; however, this strategy would require the use of a α-halomethyl phenyl sulfone or sulfide as the electrophile. Neither one of these electrophiles have been extensively used in enolate alkylations. We are aware of only one example (with PhSCH2I9) using an oxazolidinone-derived enolate by Baker and co-workers in their synthesis of milbemycin β3 in which they required extended reaction times (5 d at −20°C) to provide only 30% of the target compound.10,11 We had hoped that the matched nature of compound 14 might prove advantageous to the reaction rate and chemical yield. We were pleased to observe that the reaction proceed smoothly and in high levels of diastereoselectivity (1 h, 70% yield, 10:1 dr). Lithium borohydride reduction of 18 followed by sulfide oxidation and deoxygenation provided the desired coupling partner 3. We also investigated an alternate route that provided more direct access to 3. HWE olefination of aldehyde 4 generated the unsaturated sulfone 21 in good yield. Subsequent conjugate addition using Me2CuLi directly gave the sulfone 3. While the diastereoselectivity in the cuprate addition step was disappointing (approx. 1:1 dr), the brevity of this cuprate route is highly attractive (just 2 steps from aldehyde 4). It should also be noted that we are aware of only limited examples of conjugate addition to vinyl sulfones using cuprate or organolithium reagents.12 Recently, Feringa and co-workers have reported an elegant catalytic, asymmetric protocol for addition to α,β-unsaturated pyridyl sulfones using a monodentate phosphoramidite ligand, copper triflate and dialkylzincs; however, they were unable to facilitate the addition of dimethylzinc due to its reduced reactivity.13
Scheme 4.
Improved Routes to Sulfone Fragment.
The completion of the synthesis of cermizine D (1) is shown in Scheme 5. Deprotonation of sulfone 3 using LDA followed by addition of aldehyde 4 gave the hydroxy-sulfone as a mixture of diastereomers at both C7 and C8. It was critical that the deprotonation step be conducted with short reaction times (e.g. 1 min) as unwanted intramolecular addition to the neighboring Boc-moiety was observed with extended reaction times. The unwanted C7 diastereomer 22 could be recycled via oxidation followed by reduction with NaBH4 to regenerate a near equal (1.5:1) ratio (22:2). It should be noted that we have not independently confirmed the relative stereochemistry at C7 in either compound 22 or 2. Next, direct desulfurization of the hydroxy sulfone 2 was cleanly accomplished using Raney Ni.14 This desulfurized product proved unstable in our hands – attempts to purify by silica gel chromatography or derivatize as its Mosher ester (to establish the absolute configuration at C7) led to decomposition. Fortunately, deprotection of the crude product followed by cyclization15 generated cermizine D (1) in reasonable yield (60%, 3 steps). Comparison of our synthetic 1•TFA material with the 1H / 13C NMR and optical rotation data reported by Takayama and co-workers3,16 showed that our synthesized material was in good agreement.
Scheme 5.
Completion of the Synthesis.
In summary, a short, practical synthesis of cermizine D has been developed. Key steps in this synthesis include an organocatalyzed, heteroatom Michael addition to construct the common intermediate 4 and a sulfone-aldehyde coupling / desulfurization sequence to join the two subunits. The brevity of the outlined approach [9 steps with cuprate addition strategy (via 21) or 16 steps using the PhSCH2I alkylation approach (via 18)] compares favorably to Takayama’s 18-step approach. In addition, the common intermediate strategy provides access to over 85% of the carbon skeleton (14 of 16 carbon atoms) and both nitrogen atoms of cermizine D.
Supplementary Material
Acknowledgment
Financial support was provided by the National Institutes of Health (NIH) (GM63723). The National Science Foundation (CHE-0722319) and the Murdock Charitable Trust (2005265) are acknowledged for their support of the NMR facility. We thank Dr. Lev N. Zakharov (OSU and University of Oregon) for X-ray crystallographic analysis of compound 15 as well as Professor Max Deinzer and Dr. Jeff Morré (OSU) for mass spectra data. Finally, the authors are grateful to Professor James D. White (OSU) and Dr. Roger Hanselmann (Rib-X Pharmaceuticals) for their helpful discussions.
Footnotes
Supporting Information Available Complete experimental procedures are provided, including 1H and 13C spectra, of all new compounds. X-ray crystallographic data (CIF) for compound 15 is also provided. This material is available free of charge via the Internet at http://pubs.acs.org.
References
- 1.Morita H, Hirasawa Y, Shinato T, Kobayashi J. Tetrahedron. 2004;60:7015–7023. [Google Scholar]
- 2(a).Snider BB, Grabowski JF. J. Org. Chem. 2007;72:1039–1042. doi: 10.1021/jo062067w. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Cui L, Peng Y, Zhang L. J. Am. Chem. Soc. 2009;131:8394–8395. doi: 10.1021/ja903531g. [DOI] [PubMed] [Google Scholar]; (c) Beng TK, Gawley RE. J. Am. Chem. Soc. 2010;132:12216–12217. doi: 10.1021/ja105772z. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Cheng G, Wang X, Su D, Liu H, Liu F, Hu Y. J. Org. Chem. 2010;75:1911–1916. doi: 10.1021/jo902615u. [DOI] [PubMed] [Google Scholar]; (e) Taber DF, Guo P, Pirnot MT. J. Org. Chem. 2010;75:5737–5739. doi: 10.1021/jo100890s. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Chou S-SP, Chung Y-C, Chen P-A, Chiang S-L, Wu C-J. J. Org. Chem. 2011;76:692–695. doi: 10.1021/jo102092b. [DOI] [PubMed] [Google Scholar]
- 3(a).Nishikawa Y, Kitajima M, Takayama H. Org. Lett. 2008;10:1987–1990. doi: 10.1021/ol800574v. [DOI] [PubMed] [Google Scholar]; (b) Nishikawa Y, Kitajima M, Kogure N, Takayama H. Tetrahedron. 2009;65:1608–1617. [Google Scholar]
- 4.Carlson EC, Rathbone LK, Yang H, Collett ND, Carter RG. J. Org. Chem. 2008;73:5155–5158. doi: 10.1021/jo800749t. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5(a).Fustero S, Jimnez D, Moscard J, Cataln S, del Pozo C. Org. Lett. 2007;9:5283–5286. doi: 10.1021/ol702447y. [DOI] [PubMed] [Google Scholar]; (b) Gerasyuto AI, Hsung RP, Sydorenko N, Slafer B. J. Org. Chem. 2005;70:4248–4256. doi: 10.1021/jo050171s. [DOI] [PubMed] [Google Scholar]
- 6(a).Marigo M, Wabnitz TC, Fielenbach D, Jørgensen KA. Angew. Chem., Int. Ed. 2005;44:794–797. doi: 10.1002/anie.200462101. [DOI] [PubMed] [Google Scholar]; (b) Lin Q, Meloni D, Pan Y, Xia M, Rodgers J, Shepard S, Li M, Galya L, Metcalf B, Yue TY, Liu P, Zhou J. Org. Lett. 2009;11:1999–2002. doi: 10.1021/ol900350k. [DOI] [PubMed] [Google Scholar]
- 7.Fustero and co-workers have also developed a related, organocatalyzed approach to compound 4. Fustero S, Moscardó J, Sánchez-Roselló M, Flores S, Guerola M, del Pozo C. Tetrahedron. 2011;67:7412–7417.
- 8.Jin Y, Liu Y, Wang Z, Kwong S, Xu Z, Ye T. Org. Lett. 2010;12:1100–1103. doi: 10.1021/ol100095p. [DOI] [PubMed] [Google Scholar]
- 9.Trost BM, King SA. J. Am. Chem. Soc. 1990;112:408–422. [Google Scholar]
- 10(a).Baker R, O’Mahony MJ, Swain C. J. Chem. Soc., Chem. Commun. 1985:1326–1328. [Google Scholar]; (b) Baker R, O’Mahony MJ, Swain CJ. J. Chem. Soc., Perkin Trans 1. 1987:1623–1633. [Google Scholar]
- 11.Three reports of thio-Michael addition / diastereoselecitve protonation to α,β-unsaturated acyl oxazolidinones have also been disclosed: Tseng T-C, Wu M-J. Tetrahdedron: Asymm. 1995;6:1633–1640. Raghavan S, Tony KA. J. Org. Chem. 2003;68:5002–5005. doi: 10.1021/jo026802p. Rana NK, Singh VK. Org. Lett. 2011;13:6520–6523. doi: 10.1021/ol202808n.
- 12(a).De Chirico G, Fiandanese V, Marchese G, Naso F, Sciacovelli O. J. Chem. Soc., Chem. Commun. 1981:523–524. [Google Scholar]; (b) Ichikawa Y, Isobe M, Masaki H, Kawai T, Goto T. Tetrahedron. 1987;43:4759–4766. [Google Scholar]; (c) Dominguez E, Carretero JC. Tetrahedron Lett. 1993;34:5803–5806. [Google Scholar]
- 13.Bos PH, Maciá B, Fernández,-Ibáñez, Minnard AJ, Feringa BL. Org. Biomol. Chem. 2010;8:47–49. doi: 10.1039/b917269f. [DOI] [PubMed] [Google Scholar]
- 14.Truchot C, Wang Q, Sasaki A. Eur. J. Org. Chem. 2005:1765–1776. [Google Scholar]
- 15.Comins DL, Zheng X, Goehring RR. Org. Lett. 2002;4:1611–1613. doi: 10.1021/ol025820q. [DOI] [PubMed] [Google Scholar]
- 16.While not stated in the original isolation data, the spectroscopic data was also reported as the TFA salt of cermizine D (1). Hirasawa Y. Private communication.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.